We are live on ! Find out more
SILO icon

Silo Pharma

13 hedge funds and large institutions have $256K invested in Silo Pharma in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

405% more capital inflows, than outflows

Capital inflows: $141K | Capital outflows: $27.9K

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

3.53% more ownership

Funds ownership: 5.55% → 9.07% (+3.5%)

0% more funds holding

Funds holding: 13 → 13 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SILO Hedge Fund Activity: Q2 2025 in Review

13 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q2 2025, worth a combined $256K — down 10% from $285K a quarter earlier.

Fund positioning in SILO was balanced in Q2 2025: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 1 trimmed.

The largest buyer was AdvisorShares Investments, adding an estimated $45.8K. The largest seller was Conning Inc, exiting entirely with an estimated $23.4K sold.

  • 13 institutional investors held Silo Pharma (SILO) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $256K of Silo Pharma stock for Q2 2025, down 10% quarter-over-quarter.
  • 3 funds opened new Silo Pharma positions in Q2 2025 and 3 closed out, a net change of 0 holders.
  • The largest Silo Pharma buyer in Q2 2025 was AdvisorShares Investments, an estimated $45.8K added.
  • The largest Silo Pharma seller in Q2 2025 was Conning Inc, an estimated $23.4K sold.

Based on aggregated 13F filings for Q2 2025.